| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
STK10 |
STK10: Uncharacterized protein STK10 |
57.770 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
57.750 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
57.750 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
57.750 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
57.750 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
57.750 |
Evidence |
|
| IPO7 |
IPO7: Uncharacterized protein IPO7 |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
57.700 |
Evidence |
O
|
| XRCC6 |
XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
57.700 |
Evidence |
|
| IKBKB |
IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
57.700 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
57.700 |
Evidence |
|
| IKBKB |
IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
57.700 |
Evidence |
|
| ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
57.700 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
57.700 |
Evidence |
|
| PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
57.700 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
57.550 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
57.550 |
Evidence |
|
| VAMP1 |
VAMP1, SYB1: Vesicle-associated membrane protein 1 |
STX1A |
STX1A, STX1: Syntaxin-1A |
57.420 |
Evidence |
|
| MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
57.420 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
57.130 |
Evidence |
O
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
GRM3 |
GRM3, GPRC1C, MGLUR3: Metabotropic glutamate receptor 3 precursor |
56.780 |
Evidence |
|
| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
56.780 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
56.780 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
56.780 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
56.780 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
56.780 |
Evidence |
|
- 
-